Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Clinical trial NCT05219617 · RECRUITING
Trial details
- NCT number
- NCT05219617
- Sponsor
- SK Life Science, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2027-02-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.